Vítor Gaspar holds a PhD in Biochemistry and he is an Assistant Professor position in the University of Aveiro (Tenured), since 2024. He is also the CEO & co-founder of a start-up company Cellularis Biomodels, Lda, (https://www.cellularisbiomodels.com ) whose main focus of activity is the research, development and commercialization of 3D in vitro human models, namely disease models for discovering new cancer therapies and also on the development of new cell-based immunotherapies. He is also involved in knowledge transfer and IP management, having received in 2020 and 2023 two entrepreneurship awards and he is the corresponding co-coordinator of 8 patent applications, 2 of which are worldwide, focusing on disease models, biofabrication and bioengineered cellular therapies for human diseases, all licensed to Cellularis Biomodels. His research interests encompass the precision chemical modification of natural origin biomaterials to formulate nano-to-macro scale materials that aim to be applied in gene delivery, tissue engineering and 3D in vitro tumor models development. Currently, he is actively focusing on developing biomaterial-based 3D tumor models for high throughput in vitro screening of candidate chemotherapeutics and nanotherapeutics for gene editing. He has also recently developed a technology for generating human living materials as immunotherapeutics. He has published a total of +80 scientific articles (h-index 41) and he has been an ad-hoc reviewer for +20 international refereed top-tier journals. He is also actively involved in mentoring undergraduate/graduate students. having supervised 3 post-docs (ongoing), 11 PhD FCT fellows, (3 finished,8 ongoing) and one PhD student in a MSCA network (ongoing), having also supervised +32 master students, 3 research fellows , as well as 4 visiting researchers. He has been actively involved in the preparation, implementation and management of several project/grant proposals funded at National and European level. From 2017- 2021, he was the Principal investigator (PI) of an FCT funded National project (PANGEIA) focusing on 3D tumor models development and therapies testing validation in vitro and in vivo cancer models. He is currently a leader of two european projects and participates as team member in 5 other projects. He has participated as main jury of several academic degrees. Additionally, he has been highly involved in science outreach and public engagement activities, he is a member of scientific societies, participated as conference chair and has organized international congresses, and one international COST Actions.